Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02536118 · ClinicalTrials.gov registry record
Micra Transcatheter Pacing System Post-Approval Registry
A clinical trial of Bradycardia, sponsored by Medtronic.
- Active
- Registry status
- 3,100
- Enrollment target
- 20
- Study locations
NCT02536118: Active study of Bradycardia, sponsored by Medtronic.
NCT02536118 is a study of Bradycardia that is active but no longer recruiting, run by Medtronic. The registered enrollment target is 3,100 participants, below the 4,306-participant average among 29 other Bradycardia trials with a reported enrollment target (28% lower). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02536118, a study of Bradycardia, is active but no longer recruiting, sponsored by Medtronic.
- ACTIVE NOT RECRUITING
- Registry status
- 3,100 participants
- Enrollment target
- 20
- Study locations
Study Summary
Medtronic is sponsoring the Micra Registry to further confirm safety and effectiveness of the Micra Transcatheter Pacing System (Micra system) when used as intended, in "real-world" clinical practice, following commercial release. The Micra Registry is conducted within Medtronic's Product Surveillance Registry.
Primary Outcome
To estimate acute complication rate related to the Micra system and/or implant procedure.
Conditions Studied
Interventions
- DEVICE Micra Transcatheter Pacing System
Study Locations (20)
Florida
- - Clearwater
- - Jacksonville
- - Safety Harbor
Maryland
- - Salisbury
- - Silver Spring
- - Takoma Park
California
- - Los Angeles
- - Redwood City
Kentucky
- - Edgewood
- - Louisville
Michigan
- - Ann Arbor
- - Lansing
Alabama
- - Birmingham
Connecticut
- - New Haven
District of Columbia
- - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,100 participants |
| Start Date | 2015-07 |
| Est. Completion | 2027-04 |
What the registry record for NCT02536118 still lists
NCT02536118 is an observational study that tracks outcomes without assigning an intervention. Its 3,100 participants enrollment target places it among the larger protocols in the corpus, below the 4,306-participant average among 29 other Bradycardia trials with a reported enrollment target (28% lower).
The record links to 1 condition, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Micra Transcatheter Pacing System is the first listed.
NCT02536118 names 20 study sites across 13 states, led by Florida, Maryland, California.
Frequently Asked Questions
What is clinical trial NCT02536118 about?
NCT02536118 is a clinical study titled "Micra Transcatheter Pacing System Post-Approval Registry". Medtronic is sponsoring the Micra Registry to further confirm safety and effectiveness of the Micra Transcatheter Pacing System (Micra system) when used as intended, in "real-world" clinical practice, following commercial release. The Micra Registry is conducted within Medtronic's Product Surveilla...
What is the current status of trial NCT02536118?
This trial is currently active not recruiting. The enrollment target is 3,100 participants. The study started on 2015-07. Estimated completion is 2027-04.
What conditions does trial NCT02536118 study?
This clinical trial studies the following conditions: Bradycardia.
What interventions are being tested in trial NCT02536118?
The interventions under investigation include: Micra Transcatheter Pacing System (DEVICE).
Who is sponsoring clinical trial NCT02536118?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02536118 being conducted?
This trial has 20 study locations across Alabama, California, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bradycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02536118's enrollment target sits among peer trials
3,100 6th of 29 higher than 24 of 29 other Bradycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bradycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
Aveir VR Real-World Evidence Post-Approval Study
RECRUITING
-
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RECRUITING
-
The Alaska Oculocardiac Reflex Study
RECRUITING
-
His Bundle Pacing in Bradycardia and Heart Failure
RECRUITING
-
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
- NCT05051722 · 3,110 participants
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia